Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 12, 2017

View Archived Issues

Juno Therapeutics enters various agreements for multiple myeloma program

FDA expands orphan drug designation for patisiran

FDA grants orphan drug designation to PLX-100 for the treatment of neuronal ceroid lipofuscinoses

Janssen submits sNDA in U.S. for two new Xarelto indications

CRISPR Therapeutics applies to conduct clinical trial of CTX-001

Semi-synthetic organism encodes and retrieves increased genetic information

HMBD-004, a bispecific antibody targeting CD47 and CD33, shows promise for AML

Phase III IMmotion151 trial meets co-primary endpoints

FDA accepts BLA for galcanezumab for prevention of migraine

FDA accepts sBLA for Keytruda, grants priority review

BioVie's BIV-201 given FDA fast track designation

Topline results reported from phase II study of ARGX-113 in myasthenia gravis

Harpoon Therapeutics patents CD3-binding antibodies

Rockefeller University presents novel FXIIa inhibitors

University of California identifies new growth factors for bone regeneration

Aelin Therapeutics secures series A financing

Roche exercises option to license IONIS-HTTrx

Novel PD-1 signaling inhibitors presented by Incyte

Mereo BioPharma reports phase II results for acumapimod in COPD

FDA approves Sanofi's follow-on insulin product

Favorable initial results seen with INCB-057643 in patients with advanced cancer

PsiOxus receives milestone payment upon CTA approval for NG-348

Altimmune submits IND application for anthrax vaccine

Allergan to acquire Repros Therapeutics

Proteostasis reports data across three cystic fibrosis programs

Neurotransmitter alterations identified in novel model of ictogenesis

NIH supports new Alzheimer's Clinical Trial Consortium

NeuroVive reports interim results from phase I study of KL-1333

Almirall and Athenex to collaborate on developing KX2-391

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...